Zuhong Xu

982 total citations
10 papers, 860 citations indexed

About

Zuhong Xu is a scholar working on Aquatic Science, Renewable Energy, Sustainability and the Environment and Genetics. According to data from OpenAlex, Zuhong Xu has authored 10 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Aquatic Science, 4 papers in Renewable Energy, Sustainability and the Environment and 2 papers in Genetics. Recurrent topics in Zuhong Xu's work include Seaweed-derived Bioactive Compounds (5 papers), Algal biology and biofuel production (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Zuhong Xu is often cited by papers focused on Seaweed-derived Bioactive Compounds (5 papers), Algal biology and biofuel production (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Zuhong Xu collaborates with scholars based in China. Zuhong Xu's co-authors include Zhien Li, Quanbin Zhang, Ning Li, Hong Zhang, Xizhen Niu, Gefei Zhou, Xiaolan Lu, Xiguang Liu, Huimin Qi and Tingting Zhao and has published in prestigious journals such as Blood, International Journal of Biological Macromolecules and Carbohydrate Research.

In The Last Decade

Zuhong Xu

9 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zuhong Xu China	7	608	271	185	139	123	10	860
Xizhen Niu China	9	804 1.3×	459 1.7×	191 1.0×	167 1.2×	184 1.5×	12	1.2k
Francisco Clark Nogueira Barros Brazil	16	460 0.8×	301 1.1×	130 0.7×	154 1.1×	102 0.8×	20	812
Sara Lima Cordeiro Brazil	12	834 1.4×	306 1.1×	231 1.2×	162 1.2×	246 2.0×	12	1.0k
Olesya S. Malyarenko Russia	13	760 1.3×	185 0.7×	187 1.0×	154 1.1×	209 1.7×	17	963
Leonardo Thiago Duarte Barreto Nobre Brazil	11	702 1.2×	246 0.9×	180 1.0×	158 1.1×	181 1.5×	15	870
Т. И. Имбс Russia	13	633 1.0×	108 0.4×	186 1.0×	88 0.6×	189 1.5×	27	729
Susete Pintéus Portugal	21	776 1.3×	215 0.8×	223 1.2×	337 2.4×	218 1.8×	61	1.4k
Catarina Vizetto‐Duarte Portugal	15	380 0.6×	154 0.6×	282 1.5×	230 1.7×	125 1.0×	27	1.0k
D.T.U. Abeytunga Sri Lanka	14	322 0.5×	155 0.6×	83 0.4×	179 1.3×	45 0.4×	20	730
Hyi-Seung Lee South Korea	11	328 0.5×	110 0.4×	73 0.4×	142 1.0×	56 0.5×	17	625

Countries citing papers authored by Zuhong Xu

Since Specialization

Citations

This map shows the geographic impact of Zuhong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuhong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuhong Xu more than expected).

Fields of papers citing papers by Zuhong Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuhong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuhong Xu. The network helps show where Zuhong Xu may publish in the future.

Co-authorship network of co-authors of Zuhong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zuhong Xu. A scholar is included among the top collaborators of Zuhong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuhong Xu. Zuhong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Sun, Peng, et al.. (2025). PI3Kδ inhibitor linperlisib combined with gemcitabine and oxaliplatin for relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase Ib/II trial. Cancer Cell International. 25(1). 39–39.

Li, Zhiming, et al.. (2021). Single-Arm Phase 1b/2 Trial of the PI3Kδ Inhibitor Linperlisib Combining with Gemox in Relapsed and/or Refractory Diffuse Large B Cell Lymphoma. Blood. 138(Supplement 1). 2483–2483. 2 indexed citations

Zhao, Tingting, Quanbin Zhang, Huimin Qi, et al.. (2006). Degradation of porphyran from Porphyra haitanensis and the antioxidant activities of the degraded porphyrans with different molecular weight. International Journal of Biological Macromolecules. 38(1). 45–50. 159 indexed citations

Zhang, Quanbin, Ning Li, Tingting Zhao, et al.. (2005). Fucoidan inhibits the development of proteinuria in active Heymann nephritis. Phytotherapy Research. 19(1). 50–53. 34 indexed citations

Zhang, Quanbin, et al.. (2003). The structure of a sulfated galactan from Porphyra haitanensis and its in vivo antioxidant activity. Carbohydrate Research. 339(1). 105–111. 200 indexed citations

Zhang, Quanbin, Ning Li, Gefei Zhou, et al.. (2003). In vivo antioxidant activity of polysaccharide fraction from Porphyra haitanesis (Rhodephyta) in aging mice. Pharmacological Research. 48(2). 151–155. 212 indexed citations

Zhang, Quanbin, Zhien Li, Zuhong Xu, Xizhen Niu, & Hong Zhang. (2003). Effects of Fucoidan on Chronic Renal Failure in Rats. Planta Medica. 69(6). 537–541. 72 indexed citations

Wei, Yuxi, et al.. (2003). Inhibition of mouse liver lipid peroxidation by high molecular weight phlorotannins from Sargassum kjellmanianum. Journal of Applied Phycology. 15(6). 507–511. 20 indexed citations

Zhang, Quanbin, Pengzhan Yu, Zhien Li, et al.. (2003). Antioxidant activities of sulfated polysaccharide fractions from Porphyra haitanesis. Journal of Applied Phycology. 15(4). 305–310. 155 indexed citations

10.

Shi, Ranxin, Zuhong Xu, & Zhien Li. (2000). Antitumor activity of degraded Chondrus ocellatus polysaccharide. Haiyang yu huzhao. 31(6). 653–656. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact